Boehringer Ingelheim recalls JARDIANCE 25mg tablets due to potential label mix-up. Affected lots E61835 expire June 2025. Consumers should check packaging for correct labeling.
Labeling: Label Mix-up
Boehringer Ingelheim is recalling JARDIANCE 25mg tablets that may have incorrect labeling. This could lead to confusion about which product is being used, but it does not pose a direct health risk.
The recall is for a potential label mix-up, meaning the product might be mislabeled. This could cause confusion about which medication is being used, but it does not involve any physical harm or health risks.
People who have the JARDIANCE 25mg tablets with lot number E61835 (packaged in 30-count or 90-count bottles) and are prescribed this medication. Those with diabetes who take this drug are most at risk of confusion.
Check your JARDIANCE 25mg tablets for the lot number E61835 on the packaging. The product is sold in 30-count or 90-count bottles and expires June 2025.
Look for the lot number E61835 on the packaging of your JARDIANCE 25mg tablets.
No, this recall is for a potential label mix-up that could cause confusion but does not pose a direct health risk.
Check the lot number on your packaging. If it matches E61835, contact your doctor or pharmacist for guidance.
The affected tablets have lot number E61835 and are packaged in 30-count or 90-count bottles, expiring June 2025.
We’ve drafted a message you can send Boehringer Ingelheim to request your refund or repair — edit it as you like.
Subject: Recall D-0468-2023 — Boehringer Ingelheim Boehringer Ingelheim Hello, I own a Boehringer Ingelheim that is covered by recall D-0468-2023 from Boehringer Ingelheim. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
